LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it will be presenting at the upcoming Thomson Financial and BioCentury Future Leaders in the Biotech Industry Conference. Safi Bahcall, Ph.D., President and CEO, will discuss the Company’s oncology and inflammation drug discovery and development programs including the clinical development and novel mechanism of action of STA-4783, as well as provide a general corporate overview. The Synta presentation will begin at 3:00 PM (EST) on Thursday, March 29, 2007 and the Conference will be held at the Millennium Broadway Hotel in New York.
